title: Negative predictive value of TST and IGRA in anti-TNF treated patients.
authors.forename: Sergio
authors.initials: S
authors.lastname: Campainha
authors.forename: Teresa
authors.initials: T
authors.lastname: Gomes
authors.forename: Aurora
authors.initials: A
authors.lastname: Carvalho
authors.forename: Raquel
authors.initials: R
authors.lastname: Duarte
mesh_terms: D000068879:Adalimumab; D000328:Adult; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D059425:Interferon-gamma Release Tests; D055985:Latent Tuberculosis / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D000069442:Natalizumab; D011239:Prednisolone / Q000627:therapeutic use; D015203:Reproducibility of Results; D012189:Retrospective Studies; D014374:Tuberculin Test; D014376:Tuberculosis / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D007166:Immunosuppressive Agents; D000069442:Natalizumab; D014409:Tumor Necrosis Factor-alpha; D011239:Prednisolone; D000068879:Adalimumab; D001379:Azathioprine; D008727:Methotrexate